ArticleGlobal advances in health and medicine2020
The Use of Mobile-technologies to Deliver Integrative Medicine During and Beyond the COVID-19 World Pandemic.
Article in Global advances in health and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 10 citations in OpenAlex.
- Recommendations and guidelines of integrative medicine for COVID-19 care: The APEC project outcome.Integrative medicine research · 2024Article
- Factors relating to intention of use non-face-to-face services among family caregivers of persons with dementia: A cross-sectional study.Journal of Korean gerontological nursing · 2023Article
- SIO-ASCO guideline on integrative medicine for cancer pain management: implications for racial and ethnic pain disparities.JNCI cancer spectrum · 2023Article
- Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.British journal of cancer · 2021Observational
- The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide.Integrative cancer therapiesArticle
- Integrative Oncology Consultations Delivered via Telehealth in 2020 and In-Person in 2019: Paradigm Shift During the COVID-19 World Pandemic.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 Pandemic has catalyzed the use of tele-medicine technologies in health care, especially in cancer. The recent relaxation of guidelines has enabled rapid expansion of these platforms many have been seeking for years. We review the advantages and challenges of delivering integrative oncology care using telemedicine. The article concludes with recommendations for areas that need to be addressed so that future practice can consider a hybrid model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.